로딩 중…
지수 로딩 중…
Harrow Health, Inc.
HROW· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$42.87+2.22%
2026-06-18
Price Chart
Harrow Health, Inc.+36.01%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.60B |
| Revenue | $269M |
| Net Income | $-15M |
| Total Assets | $420M |
| Net Assets | $29M |
| Value | |
| P/B | 55.67x |
| P/S | 5.95x |
| EV/EBITDA | 45.18x |
| FCF Yield | 0.89% |
| Profitability | |
| ROE | -52.12% |
| ROA | -3.57% |
| Op. Margin | 10.47% |
| Revenue Growth | -7.58% |
| Financial Health | |
| Debt Ratio | 1362.75% |
| Total Debt | $301M |
| FCF | $14M |
| Cash | $95M |
| Current Ratio | 2.48x |
| Net Debt/EBITDA | 5.16x |
| Performance | |
| 1Y Return | 36.01% |
| 1M Return | 39.73% |
| From 52W High | -21.84% |
| 1Y MDD | -47.03% |
| Trading | |
| Volume | 1,028,613 shares |
| Trading Value | $44M |
| Per Share | |
| EPS | $-0.14 |
| BPS | $1.43 |